Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
FierceBiotech2d
Metsera links GLP-1 drug to 11% weight loss after 12 weeks, teeing up trial of monthly dosing
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
Medpage Today on MSN3d
Gabapentin May Not Raise the Risk of Falling After All
Newer evidence has suggested, however, that gabapentin may not work for all pain conditions and is associated with falls. As ...
FiercePharma9d
Teva looks to peel back the onion on mental health: exec
After reinvigorating a decades-old schizophrenia drug in an innovative long-acting treatment option, Teva is looking to ...
BioSpace7d
Axsome Posts Mixed Phase III Data in Alzheimer’s Agitation, Plans FDA Filing
With two earlier trials meeting their primary endpoints, Axsome claimed it has the data to support a filing for FDA approval ...
Hosted on MSN6d
SUNY Potsdam gets $600K grant to research specific protein
Research at SUNY Potsdam is helping shed new light on a specific protein and how it affects people’s health. Although no ...
AZoM on MSN2d
Amorphous Organic-Hybrid Vanadium Oxide for Aqueous Zinc-Ion Batteries
AOH-VO, an innovative material for aqueous zinc-ion batteries, offers ultrafast charging and exceptional stability through ...
Medscape4d
Doxazosin and Congestive Heart Failure
In this study, doxazosin titration occurred on a monthly basis ... inordinately high rate of CHF in the study population. For example, a blockers increase plasma volume, may increase plasma ...